Diversity and Dosage Determine the Efficacy of the Probiotic SYN ‐53 in Allergic Rhinoconjunctivitis: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Documenti analoghi

• Effect of the Multi‐Strain Probiotic SYN ‐53 in the Management of Allergic Rhinoconjunctivitis
  di: Karl‐Christian Bergmann, et al.
  Pubblicazione: (2025)
• Efficacy of Using Photobiomodulation Therapy in Allergic Rhinitis: A Placebo‐Controlled Randomized Clinical Trial
  di: Patrícia Costa Oliveira, et al.
  Pubblicazione: (2025)
• Comparative Efficacy of Intranasal Corticosteroids and Antihistamines in Enhancing Paediatric Quality of Life in Allergic Rhinoconjunctivitis
  di: Ellen Tameeris, et al.
  Pubblicazione: (2026)
• Letter to the Editor Regarding “Efficacy of Using Photobiomodulation Therapy in Allergic Rhinitis: A Placebo‐Controlled Randomized Clinical Trial”
  di: Sanjeev Yadav, et al.
  Pubblicazione: (2025)
• Our Response Letter to the Editor Concerning “Efficacy of Using Photobiomodulation Therapy in Allergic Rhinitis: A Placebo‐Controlled Randomized Clinical Trial”
  di: Patrícia Costa Oliveira, et al.
  Pubblicazione: (2025)